MedPath

Safety and immunogenicity of rabies vaccines in animal bite cases administered using new one week intradermal regime

Phase 3
Completed
Conditions
Health Condition 1: null- Animal bite cases
Registration Number
CTRI/2012/12/003230
Lead Sponsor
Department of Community Medicine Kempegowda Institute of Medical Sciences KIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1) Animal bite cases with category II & III reporting within 72 hours of exposure

2) Subjects willing to give signed informed consent

3) Subjects willing to give blood samples on days 0,14,90

Exclusion Criteria

1) Subjects who have received anti rabies vaccine and any type of anti-sera in the past.

2) Subjects with chronic diseases like Diabetes Mellitus, Hypertension and Tuberculosis.

3) Subjects who are immunocompromised & are on immunosuppressive therapy like long acting steroids, anti cancer drugs & radiation therapy.

4) Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath